Full View

A comparison of the acid‐inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism

NG Hunfeld - Alimentary pharmacology & therapeutics, 2010 - Wiley Online Library
Background Esomeprazole and pantoprazole are metabolized in the liver and the
polymorphic CYP2C19 enzyme is involved in that process. This genetic polymorphism …
被引用次数：60 相关文章
[PDF] eur.nl

[PDF][PDF] A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism

NGM Hunfeld, DJ Touw, RA Mathot… - Clinical effects of …, 2010 - repub.eur.nl
Background Esomeprazole and pantoprazole are metabolized in the liver and the
polymorphic CYP2C19 enzyme is involved in that process. This genetic polymorphism …
[PDF] eur.nl

[PDF][PDF] A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism

NGM Hunfeld, DJ Touw, RA Mathot… - Clinical effects of proton …, 2010 - pure.eur.nl
Background Esomeprazole and pantoprazole are metabolized in the liver and the
polymorphic CYP2C19 enzyme is involved in that process. This genetic polymorphism …

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism

NG Hunfeld, DJ Touw, RA Mathot, PGH Mulder… - 2010 - pubmed.ncbi.nlm.nih.gov
Background Esomeprazole and pantoprazole are metabolized in the liver and the
polymorphic CYP2C19 enzyme is involved in that process. This genetic polymorphism …

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism.

NG HUNFELD, DJ TOUW… - Alimentary …, 2010 - search.ebscohost.com
Background Esomeprazole and pantoprazole are metabolized in the liver and the
polymorphic CYP2C19 enzyme is involved in that process. This genetic polymorphism …

A comparison of the acid‐inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism

NG HUNFELD, DJ TOUW, RA MATHOT… - Alimentary …, 2009 - infona.pl
Background Esomeprazole and pantoprazole are metabolized in the liver and the
polymorphic CYP2C19 enzyme is involved in that process. This genetic polymorphism …

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism.

NG Hunfeld, DJ Touw, RA Mathot… - Alimentary …, 2010 - europepmc.org
Background Esomeprazole and pantoprazole are metabolized in the liver and the
polymorphic CYP2C19 enzyme is involved in that process. This genetic polymorphism …

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism

NG Hunfeld, DJ Touw… - Alimentary …, 2010 - researchinformation.amsterdamumc …
Esomeprazole and pantoprazole are metabolized in the liver and the polymorphic CYP2C19
enzyme is involved in that process. This genetic polymorphism determines fast (70% of …

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism

NG Hunfeld, DJ Touw, RA Mathot… - Alimentary …, 2010 - research.rug.nl
Background: Esomeprazole and pantoprazole are metabolized in the liver and the
polymorphic CYP2C19 enzyme is involved in that process. This genetic polymorphism …

[引用][C] A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorph ism

NG HUNFELD, DJ TOUW, RA MATHOT… - Alimentary …, 2010 - pascal-francis.inist.fr
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to
pharmacokinetics and CYP2C19 polymorph ism CNRS Inist Pascal-Francis CNRS Pascal …